NEWS
Trial pill may slow or even start to reverse Alzheimer’s
WELLINGTON: A world-first trial of a pill that may reverse the decline in cognitive function… read more
Optimism for sector from Arvida after high price sellout
AUCKLAND: The proposed acquisition of Arvida Group by US private equity firm Stonepeak injects “meaningful… read more









